Prevail Innovative Wealth Advisors’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-110,374
Closed -$2.09M 205
2025
Q4
$2.09M Sell
110,374
-6,755
-6% -$128K 0.37% 94
2025
Q3
$2.16M Buy
117,129
+13,592
+13% +$222K 0.42% 84
2025
Q2
$1.6M Buy
103,537
+41,143
+66% +$637K 0.36% 101
2025
Q1
$1.01M Buy
62,394
+25,607
+70% +$440K 0.27% 105
2024
Q4
$590K Buy
+36,787
New +$653K 0.17% 117
2024
Q3
Sell
-70,138
Closed -$1.22M 183
2024
Q2
$1.22M Buy
70,138
+10,844
+18% +$181K 0.43% 81
2024
Q1
$1,000K Buy
59,294
+10,914
+23% +$186K 0.37% 93
2023
Q4
$802K Buy
48,380
+17,899
+59% +$275K 0.38% 75
2023
Q3
$474K Buy
30,481
+14,240
+88% +$238K 0.25% 88
2023
Q2
$277K Buy
+16,241
New +$282K 0.15% 89

Other funds holding HQH

Prevail Innovative Wealth Advisors's HQH Position: Q1 2026 in Review

Prevail Innovative Wealth Advisors sold out of abrdn Healthcare Investors (HQH) in Q1 2026, closing a stake of 110,374 shares — an estimated $2.09M sold.

Prevail Innovative Wealth Advisors first reported a position in HQH in Q2 2023 and held it in 10 quarters. The position peaked at $2.16M in Q3 2025. 128 funds tracked by Wall St. Rank hold HQH as of Q1 2026.

  • Prevail Innovative Wealth Advisors reported no remaining abrdn Healthcare Investors position as of Q1 2026 after selling out during the quarter.
  • Prevail Innovative Wealth Advisors sold 110,374 abrdn Healthcare Investors shares in Q1 2026, an estimated $2.09M.
  • Prevail Innovative Wealth Advisors first reported a position in abrdn Healthcare Investors in Q2 2023 and held it in 10 quarters.
  • Prevail Innovative Wealth Advisors's abrdn Healthcare Investors position peaked at $2.16M in Q3 2025.
  • 128 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q1 2026.

Based on Prevail Innovative Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.